Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.870
-0.170 (-3.37%)
At close: Aug 26, 2026, 4:00 PM EDT
4.910
+0.040 (0.82%)
Pre-market: Aug 27, 2026, 5:44 AM EDT
Coya Therapeutics Revenue
Coya Therapeutics had revenue of $243.75K in the quarter ending June 30, 2026, with 48.97% growth. This brings the company's revenue in the last twelve months to $8.02M, up 1,793.76% year-over-year. In the year 2025, Coya Therapeutics had annual revenue of $7.95M with 123.57% growth.
Revenue (ttm)
$8.02M
Revenue Growth
+1,793.76%
P/S Ratio
14.25
Revenue / Employee
$1,002,393
Employees
8
Market Cap
114.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.95M | 4.39M | 123.57% |
| Dec 31, 2024 | 3.55M | -2.45M | -40.79% |
| Dec 31, 2023 | 6.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Seer, Inc. | 14.22M |
| Rani Therapeutics Holdings | 4.88M |
| NeOnc Technologies Holdings | 39.99K |
| Genelux | 8.00K |
| Fractyl Health | 3.00K |
COYA News
- 16 days ago - Coya Therapeutics reports Q2 EPS (28c), consensus (36c) - TheFly
- 16 days ago - Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - Business Wire
- 16 days ago - Coya Therapeutics Quarterly report: Q2 2026 - Filings
- 16 days ago - Coya Therapeutics Earnings release: Q2 2026 - Filings
- 20 days ago - Coya Therapeutics Slides: Investor presentation - Filings
- 2 months ago - Coya Therapeutics Slides: Investor presentation - Filings
- 2 months ago - Coya Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - Coya Therapeutics Transcript: Investor update - Transcripts